Gravitas

Trial description
A Randomized, Double-Blind, Placebo-Controlled Phase 3 Study of Itacitinib or Placebo in Combination With Corticosteroids for the Treatment of First-Line Acute Graft Versus-Host Disease
Contact name
Dr Pramila Krishnamurthy
Trial start date
Wednesday, May 30, 2018
Trial end date
Thursday, January 31, 2019
Trial tumour type
Haematological
Show on Radiotherapy
No